Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ST13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HSDL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAP1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BAG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGF12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOSC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB27A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RYK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDELR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5orf24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NAPG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IPO5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MARCKS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPY30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METTL2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on